Overview

Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial

Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
RESEARCH HYPOTHESIS -Incidence of preterm delivery is lower in women treated with oral micronized progesterone (Utrogestan) as acute tocolysis agent compare to Nifedipine group with fewer maternal side effect
Phase:
Phase 2
Details
Lead Sponsor:
nor zila hassan malek
Treatments:
Nifedipine
Progesterone